vTv Therapeutics Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day streak of losses despite Middle East clashes
- Oil rises 1%, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Google escapes ad tech breakup in third Big Tech antitrust loss for US
vTv Therapeutics (VTVT) IPO Opens 7% Lower
July 30, 2015 10:37 AM EDTToday's IPO for vTv Therapeutics (NASDAQ: VTVT) opened for trading at $14 after pricing 7,812,500 shares of its Class A common stock at a price to the public of $15 per share, the low end of the expected $15-$17 range.
Piper Jaffray & Co. and Stifel... More
